| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j4988Q |
| P356 | DOI | 10.1371/JOURNAL.PONE.0104988 |
| P932 | PMC publication ID | 4138167 |
| P698 | PubMed publication ID | 25136927 |
| P5875 | ResearchGate publication ID | 264861581 |
| P2093 | author name string | Shuang Liu | |
| Jin-Lan Zhang | |||
| Feng Qu | |||
| Zhong-Ping Duan | |||
| Cai-Sheng Wu | |||
| Su-Jun Zheng | |||
| P2860 | cites work | Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. | Q50959265 |
| Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. | Q54584941 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension | Q59288238 | ||
| [Diagnostic and treatment guidelines for liver failure] | Q80331843 | ||
| [The guidelines of prevention and treatment for chronic hepatitis B] | Q82618536 | ||
| Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma | Q83069706 | ||
| Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model | Q83766864 | ||
| Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study | Q83791191 | ||
| Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice | Q84822163 | ||
| Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure | Q85053648 | ||
| Sphingolipids: a potential molecular approach to treat allergic inflammation | Q21296721 | ||
| Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection | Q27486112 | ||
| Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics | Q27490520 | ||
| Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 | ||
| Hepatitis B virus infection--natural history and clinical consequences | Q29617961 | ||
| Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis | Q34086900 | ||
| Acute-on-chronic liver failure: pathophysiological basis of therapeutic options | Q34116165 | ||
| Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide | Q34540731 | ||
| The new liver allocation system: moving toward evidence-based transplantation policy | Q34802534 | ||
| Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics | Q35324757 | ||
| Advances in critical care hepatology | Q35605215 | ||
| Sphingolipid signalling: molecular basis and role in TNF-alpha-induced cell death. | Q35677103 | ||
| Apoptosis and necrosis in the liver: a tale of two deaths? | Q36382247 | ||
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). | Q37577568 | ||
| Biomarker and drug discovery for gastroenterology through translational bioinformatics | Q37774737 | ||
| Role of lipids in virus replication | Q37882865 | ||
| Sphingolipid metabolism and analysis in metabolic disease | Q37930541 | ||
| Hepatocarcinogenesis and ceramide/cholesterol metabolism | Q37951543 | ||
| Acute-on chronic liver failure. | Q38023100 | ||
| Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite | Q39326317 | ||
| Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication | Q39590608 | ||
| Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment | Q40069371 | ||
| Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model | Q40272019 | ||
| Sphingolipid signalling and liver diseases | Q42616221 | ||
| Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease | Q43138779 | ||
| Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection | Q45414031 | ||
| Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. | Q45765597 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sphingolipids | Q410395 |
| liver failure | Q970208 | ||
| P304 | page(s) | e104988 | |
| P577 | publication date | 2014-08-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure | |
| P478 | volume | 9 |
| Q36269654 | Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure |
| Q92276262 | Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats |
| Q41620908 | Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B. |
| Q59350886 | Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection |
Search more.